Demand Built From Source Data
Catchment, payer mix, and regulator licensing data, not a market-size headline divided by a guess.
Feasibility StudyA feasibility study is only useful if it can say no.
Most feasibility studies are written to confirm a decision already taken, and lenders and investors know it. Ours are built to be tested: demand from regulator and payer data rather than a market-report headline, costs from current fee schedules and quotes, and a base, upside and downside case with every assumption labelled. A bank can lend against it, a board can decline on it, and either way the money is not committed on hope.
Fixed fee. Bank-ready study for a clinic, pharmacy or SME, AED 25,000 to 60,000. Investor-grade study for a hospital, manufacturing or PPP project, from AED 150,000. Scoped in writing before we start.
Who engages this
Doctors and operators putting a clinic, day-surgery centre or diagnostic unit in front of a bank. Pharmaceutical and device companies deciding whether to localise manufacturing in the UAE or Saudi Arabia. Investors and family offices weighing a hospital, a chain or a PPP bid. International entrants who need a study a UAE lender or free-zone authority will accept, and anyone who needs a feasibility study for a licence application or an investor visa and wants one that holds up afterwards.
The work
What this practice takes on.
Costs From Current Schedules
Government fees, fit-out and equipment quotes, staffing at DHA or DoH ratios, and insurance empanelment timing.
Three Cases, Assumptions Labelled
Base, upside and downside, with the assumption behind each number stated so it can be challenged.
Bank and Lender Format
Structured to the sections UAE lenders and free-zone authorities expect, with the financial model delivered alongside.
Investor-Grade Studies
Hospital, manufacturing localisation and PPP cases built to the standard a sovereign or institutional investor applies.
The No Case
Where the numbers do not work, the study says so, and what would have to change for them to work.
On a mandate
A regional pharmaceutical distributor asked whether to build a secondary-manufacturing plant in Abu Dhabi to meet local-content requirements. The base case cleared the hurdle rate only if a government offtake was signed before ground was broken; the downside case did not clear it at all. The study said so, and set out the offtake terms that would change the answer. The client used it to negotiate the offtake first and committed capital eight months later than planned, on terms the study had specified.
Questions
What clients ask first.
Will a bank accept your study?
The bank-ready study is structured to the sections UAE lenders ask for, with the financial model delivered alongside so the credit team can test the assumptions themselves. We state the method and the sources, which is what a credit committee looks for first.
How long does a feasibility study take?
Three to four weeks for a bank-ready study on a single facility or SME; six to ten weeks for an investor-grade study, depending on the data the client can provide and whether site or regulator work is needed.
What if the study shows the project does not work?
Then you have been saved the capital, and the study sets out what would have to change. Our fee does not depend on the answer, and we do not revise a conclusion to suit the application it is attached to.
Can the study support an investor visa or licence application?
Yes. The format satisfies what free-zone authorities and the visa route ask for, but the content is the same as the bank study: a plan you can actually run, not a document written to be filed and forgotten.
If capital is about to be committed on a study nobody has tested, test it first.
Further reading
Related insights
Market Access
UAE pharma manufacturing: a nine-stage build
The nine-stage path from feasibility to WHO or EU GMP certification for UAE pharmaceutical manufacturing, and why localisation incentives do not shorten the qualification clock.
Infrastructure BriefAbu Dhabi's AED 55bn PPP pipeline: position now
Abu Dhabi's AED 55 billion PPP pipeline opens a health-infrastructure opportunity that rewards sponsors who arrive with grounded feasibility and a bankable financial model.
Strategy BriefEntering UAE healthcare: the sequence that works
Why UAE healthcare entries fail on sequence rather than strategy, and the order that actually works.